title: [From epidemiology to therapeutic choices. Infections in patients with neutropenia].
abstract: CHANGING EPIDEMIOLOGY: In hermtology units, Gram positive germs are becoming more predominate than Gram negative germs for reasons related both to changing clinical practices and to the epidemiology of infectious diseases. Nevertheless, mortality due to Gram negative germs, particularly Pseudomonas, remains high and justifies continued application of a rule established more than 20 years ago concerning the requirement, in neutropenic patients, to aim antibiotics against the most eminetly dangerous germs. FOR HIGH RISK PATIENTS: Patients with severe prolonged neutropenia, the betalactam-aminoglycoside combination is still indicated in most cases due to its spectrum, bacteriocidal rate and synergetic action. According to the most recent randomized trials, adding a first intention glycopeptide, except in specific situations (suspected infected catheter, high incidence of methicillin-resistant Staphylococcus aureus), would not be justified. FOR LOW RISK PATIENTS: Single drug regimens are still indicated if a wide spectrum compound is used, especially for Gram negative germs. Several trials in outpatients have been attempted, but patients selection criteria remain to be defined. WHICH ANTIBIOTIC? Choosing the right antibiotic, for both high-risk and low-risk patients, requires knowledge of the causal germs generally encountered in the unit. The choice may vary over time depending on germ ecology within the unit and whether an in- or out-patient is to be treated.
authors.affiliation: Service d'Hématologie clinique, Hôpital Henri Mondor, Créteil.
authors.forename: C
authors.initials: C
authors.lastname: Cordonnier
authors.forename: N
authors.initials: N
authors.lastname: Dhedin
authors.forename: C
authors.initials: C
authors.lastname: Rieux
authors.forename: K
authors.initials: K
authors.lastname: Belhadj
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology*; D006801:Humans; D009503:Neutropenia / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology; D012307:Risk Factors; D013997:Time Factors
chemical_list: D000900:Anti-Bacterial Agents
vernacular_title: De l'épidémiologie aux choix thérapeutiques. Infections chez les patients neutropéniques.